{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK7",
        "Protein_Change": {
          "ref": "M",
          "alt": "I",
          "position": "26"
        },
        "variant_string_id": "PARK7 M26I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PARK7 DJ-1 have been associated with autosomal-recessive early-onset Parkinson's disease (PD). DJ-1 encodes for an atypical peroxiredoxin-like peroxidase that may act as a regulator of transcription and a redox-dependent chaperone.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for the variant, linking PARK7 mutations to PD through loss-of-function and potential gain-of-function mechanisms."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used yeast two-hybrid screening and co-immunoprecipitation experiments to identify and validate interactions between DJ-1 mutants and TTRAP, a novel interactor.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (protein interaction assays) effectively models the disease pathogenesis by investigating how mutant DJ-1 proteins alter protein-protein interactions, which is relevant to PD mechanisms.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper describes the use of controls including wild-type DJ-1 and empty vectors, and mentions that experiments were repeated in duplicate or more with at least two independent clones used for each cell line.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were used, meeting the criteria for proceeding to evaluate variant controls.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study compared the interactions and effects of M26I and L166P mutants with wild-type DJ-1, showing that mutants had stronger binding to TTRAP and blocked its protective activity.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (M26I and L166P) were used as controls, and their effects were compared to wild-type DJ-1, indicating a clear difference in behavior that is relevant to PD pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper provides statistical analysis showing significant differences in cell viability and apoptosis between cells expressing mutant DJ-1 and controls, with p-values indicating statistical significance.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses support the conclusion that M26I exerts a pro-apoptotic effect by blocking TTRAP protective activity, indicating a pathogenic role.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "While the paper does not directly calculate OddsPath, the robust statistical significance (p<0.002) of the pro-apoptotic effects of M26I suggests a high likelihood of pathogenicity.",
          "judgment": "Yes",
          "reasoning": "Given the strong statistical support for the pathogenic effects of M26I, the evidence strength is inferred to be at least moderate.",
          "next_step_or_outcome": "Assign PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The M26I variant in PARK7 demonstrates a pathogenic effect through enhanced interaction with TTRAP and inhibition of its protective activity, supported by robust statistical evidence, warranting a PS3_moderate classification."
    },
    {
      "variant_id": {
        "Gene": "PARK7",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "PARK7 L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PARK7 DJ-1 have been associated with autosomal-recessive early-onset Parkinson's disease (PD). DJ-1 encodes for an atypical peroxiredoxin-like peroxidase that may act as a regulator of transcription and a redox-dependent chaperone.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for the variant, linking PARK7 mutations to PD through loss-of-function and potential gain-of-function mechanisms."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used yeast two-hybrid screening and co-immunoprecipitation experiments to identify and validate interactions between DJ-1 mutants and TTRAP, a novel interactor.",
          "judgment": "Yes",
          "reasoning": "The general class of assay used (protein interaction assays) effectively models the disease pathogenesis by investigating how mutant DJ-1 proteins alter protein-protein interactions, which is relevant to PD mechanisms.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper describes the use of controls including wild-type DJ-1 and empty vectors, and mentions that experiments were repeated in duplicate or more with at least two independent clones used for each cell line.",
          "judgment": "Yes",
          "reasoning": "Basic controls and replicates were used, meeting the criteria for proceeding to evaluate variant controls.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study compared the interactions and effects of M26I and L166P mutants with wild-type DJ-1, showing that mutants had stronger binding to TTRAP and blocked its protective activity.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (M26I and L166P) were used as controls, and their effects were compared to wild-type DJ-1, indicating a clear difference in behavior that is relevant to PD pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper provides statistical analysis showing significant differences in cell viability and apoptosis between cells expressing mutant DJ-1 and controls, with p-values indicating statistical significance.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses support the conclusion that L166P exerts a pro-apoptotic effect by blocking TTRAP protective activity, indicating a pathogenic role.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "While the paper does not directly calculate OddsPath, the robust statistical significance (p<0.002) of the pro-apoptotic effects of L166P suggests a high likelihood of pathogenicity.",
          "judgment": "Yes",
          "reasoning": "Given the strong statistical support for the pathogenic effects of L166P, the evidence strength is inferred to be at least moderate.",
          "next_step_or_outcome": "Assign PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The L166P variant in PARK7 demonstrates a pathogenic effect through enhanced interaction with TTRAP and inhibition of its protective activity, supported by robust statistical evidence, warranting a PS3_moderate classification."
    }
  ]
}